APA (7th ed.) Citation

Boesing, M., Abig, K., Brändle, M., Brutsche, M., Burri, E., Frye, B. C., . . . Leuppi, J. D. (2022). Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: Study protocol for a randomized, placebo-controlled, and multicenter trial. Trials, 23(1), 1. https://doi.org/10.1186/s13063-022-06723-w

Chicago Style (17th ed.) Citation

Boesing, Maria, et al. "Inhaled Aviptadil for the Possible Treatment of COVID-19 in Patients at High Risk for ARDS: Study Protocol for a Randomized, Placebo-controlled, and Multicenter Trial." Trials 23, no. 1 (2022): 1. https://doi.org/10.1186/s13063-022-06723-w.

MLA (9th ed.) Citation

Boesing, Maria, et al. "Inhaled Aviptadil for the Possible Treatment of COVID-19 in Patients at High Risk for ARDS: Study Protocol for a Randomized, Placebo-controlled, and Multicenter Trial." Trials, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1186/s13063-022-06723-w.